Inception Return
(2/28/2007)
|
4.72 %
|
|
YTD Return
|
5.22 %
|
|
NAVPS
(6/7/2023)
|
$9.63
|
|
Change
|
($0.07) / -0.68 %
|
|
|
Growth of $10,000
(As of April 30, 2023)
|
|
MER
|
2.45 %
|
|
Assets ($mil)
|
$8,987.38
|
|
Rank (1Yr)
|
1528/1743
|
|
Std Dev (3Yr)
|
8.81 %
|
|
Volatility Ranking (3Yr)
|
4/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or Back
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
5.50 %
|
|
Sales Status
|
Open
|
|
|
Objective
This fund's objective is to generate income and long term capital growth by investing, directly or indirectly, in a combination of equity and fixed income securities of companies located anywhere in the world. Indirect investments may include convertible securities, derivatives, equity-related securities and securities of other mutual funds.
|
Fund Manager
CI Investments Inc
Portfolio Manager
Drummond Brodeur, CI Investments Inc
Geof Marshall, CI Investments Inc
John Shaw, CI Investments Inc
Matthew Strauss , CI Investments Inc
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of April 30, 2023)
|
Sector Allocation
(As of April 30, 2023)
|
Geographic Allocation
(As of April 30, 2023)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| United States Treasury 4.13% 15-Nov-2032 | Foreign Bonds | Fixed Income | United States | 5.00% |
| United States Treasury 4.00% 15-Nov-2052 | Foreign Bonds | Fixed Income | United States | 4.33% |
| United States Treasury 0.38% 31-Oct-2023 | Cash and Equivalents | Cash and Cash Equivalent | United States | 3.39% |
| United States Treasury 1.13% 31-Oct-2026 | Foreign Bonds | Fixed Income | United States | 2.80% |
| Usd Cash Sweep | Cash and Equivalents | Cash and Cash Equivalent | United States | 2.62% |
| Apple Inc | US Equity | Technology | United States | 2.38% |
| United States Treasury 0.00% 31-Aug-2023 | Cash and Equivalents | Cash and Cash Equivalent | United States | 2.14% |
| Microsoft Corp | US Equity | Technology | United States | 2.03% |
| Shell PLC | International Equity | Energy | European Union | 1.93% |
| Eli Lilly and Co | US Equity | Healthcare | United States | 1.86% |
Performance Data
(As of April 30, 2023)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
1.31
|
0.82
|
7.35
|
5.22
|
1.02
|
6.06
|
4.87
|
6.50
|
|
Benchmark
|
1.29
|
2.55
|
10.34
|
6.48
|
6.28
|
3.70
|
4.65
|
7.69
|
|
Quartile Ranking
|
2
|
3
|
3
|
3
|
4
|
2
|
2
|
1
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-12.86
|
13.56
|
12.53
|
11.83
|
-2.20
|
8.63
|
1.69
|
10.46
|
11.30
|
16.55
|
|
Benchmark
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
12.44
|
18.86
|
|
Quartile Ranking
|
4
|
1
|
1
|
3
|
2
|
1
|
4
|
1
|
1
|
1
|